99 results
8-K
EX-2.1
NEPH
Nephros Inc
21 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:01pm
.
1.22 “Other Components” means any and all components other than Products used for or in connection with collection and preparation of environmental … ” means any and all chemicals used for or in connection with collection and preparation of environmental or clinical samples for analysis by qPCR, including
8-K
EX-99.2
yhuso901 pt6
13 Jan 22
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022
7:30am
D/A
ozx9hf
7 Sep 21
$2.44M in securities to be acquired, sold $2.1M, 19 investors
4:06pm
D
vyi2r2k5tcgcyvk4xhm
14 Jul 21
$1.2M in equity, sold $1.2M, 1 investor
12:00am
D/A
0w6q649jf2fdrfp 0s
4 Sep 20
$2.44M in securities to be acquired, sold $2M, 19 investors
2:35pm
8-K
EX-1.1
x65wgjnwvl7gmb ej94
31 Jan 20
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
10:44am